The First Fermi-LAT SNR Catalog and Cosmic Ray Implications

While supernova remnants (SNRs) are widely thought to be powerful cosmicray accelerators, indirect evidence comes from a small number of well-studied cases. Here we systematically determine the gamma-ray emission detected by the Fermi Large Area Telescope (LAT) from all known Galactic SNRs, disentangling them from the sea of cosmic-ray generated photons in the Galactic plane. Using LAT data we have characterized the 1-100 GeV emission in 279 regions containing SNRs, accounting for systematic uncertainties caused by source misattribution and instrumental response. We classified 30 sources as SNRs, using spatial overlap with the radio emission position. For all the remaining regions we evaluated upper limits on SNRs' emission. In the First Fermi -LAT SNR Catalog there is a study of the common characteristics of these SNRs, such as comparisons between GeV, radio and TeV quantities. We show that previously satisfactory models of SNRs' GeV emission no longer adequately describe the data. To address the question of cosmic ray (CR) origins, we also examine the SNRs' maximal CR contribution assuming the GeV emission arises solely from proton interactions. Improved breadth and quality of multiwavelength (MW) data, including distances and local densities, and more, higher resolution gamma-ray data with correspondingly improved Galactic diffuse models will strengthen this constraint

Setting the stage for acute-on-chronic kidney injury

Acute-on-chronic kidney disease will be familiar to many nephrologists. Hsu et al. quantify the risk of acute-on-chronic disease across the stages of preexisting chronic kidney disease. Their study demonstrates the valuable insights that large epidemiological studies can bring to the field of acute kidney injury

Doping dependence of the superconducting gap in Bi2Sr2CaCu2O{8 + delta}

Bi2Sr2CaCu2O{8 + \delta} crystals with varying hole concentrations (0.12 < p < 0.23) were studied to investigate the effects of doping on the symmetry and magnitude of the superconducting gap. Electronic Raman scattering experiments that sample regions of the Fermi surface near the diagonal (B_{2g}) and principal axes (B_{1g}) of the Brillouin Zone have been utilized. The frequency dependence of the Raman response function at low energies is found to be linear for B_{2g} and cubic for B_{1g} (T< T_c). The latter observations have led us to conclude that the doping dependence of the superconducting gap is consistent with d_{x^2-y^2} symmetry, for slightly underdoped and overdoped crystals. Studies of the pair-breaking peak found in the B_{1g} spectra demonstrate that the magnitude of the maximum gap decreases monotonically with increasing hole doping, for p > 0.12. Based on the magnitude of the B_{1g} renormalization, it is found that the number of quasiparticles participating in pairing increases monotonically with increased doping. On the other hand, the B_{2g} spectra show a weak "pair-breaking peak" that follows a parabolic-like dependence on hole concentration, for 0.12 < p < 0.23.Comment: 9 pages REvTex document including 8 eps figures; new table II; changes to Fig. 5 and tex

Hole concentration and phonon renormalization in Ca-doped YBa_2Cu_3O_y (6.76 < y < 7.00)

In order to access the overdoped regime of the YBa_2Cu_3O_y phase diagram, 2% Ca is substituted for Y in YBa_2Cu_3O_y (y = 7.00,6.93,6.88,6.76). Raman scattering studies have been carried out on these four single crystals. Measurements of the superconductivity-induced renormalization in frequency (Delta \omega) and linewidth (\Delta 2\gamma) of the 340 cm^{-1} B_{1g} phonon demonstrate that the magnitude of the renormalization is directly related to the hole concentration (p), and not simply the oxygen content. The changes in \Delta \omega with p imply that the superconducting gap (\Delta_{max}) decreases monotonically with increasing hole concentration in the overdoped regime, and \Delta \omega falls to zero in the underdoped regime. The linewidth renormalization \Delta 2\gamma is negative in the underdoped regime, crossing over at optimal doping to a positive value in the overdoped state.Comment: 18 pages; 5 figures; submitted to Phys. Rev. B Oct. 24, 2002 (BX8292

Optical symmetries and anisotropic transport in high-Tc superconductors

A simple symmetry analysis of in-plane and out-of-plane transport in a family of high temperature superconductors is presented. It is shown that generalized scaling relations exist between the low frequency electronic Raman response and the low frequency in-plane and out-of-plane conductivities in both the normal and superconducting states of the cuprates. Specifically, for both the normal and superconducting state, the temperature dependence of the low frequency $B_{1g}$ Raman slope scales with the $c-$axis conductivity, while the $B_{2g}$ Raman slope scales with the in-plane conductivity. Comparison with experiments in the normal state of Bi-2212 and Y-123 imply that the nodal transport is largely doping independent and metallic, while transport near the BZ axes is governed by a quantum critical point near doping $p\sim 0.22$ holes per CuO$_{2}$ plaquette. Important differences for La-214 are discussed. It is also shown that the $c-$ axis conductivity rise for $T\ll T_{c}$ is a consequence of partial conservation of in-plane momentum for out-of-plane transport.Comment: 16 pages, 8 Figures (3 pages added, new discussion on pseudogap and charge ordering in La214

The doping dependence of T* - what is the real high-Tc phase diagram?

Underdoped high-Tc superconductors are frequently characterised by a temperature, T*, below which the normal-state pseudogap opens. Two different "phase diagrams" based on the doping (p) dependence of T* are currently considered: one where T* falls to zero at a critical doping state and the other where T* merges with Tc in the overdoped region. By examining the temperature dependence of the NMR Knight shift and relaxation rate, entropy, resistivity, infrared conductivity, Raman scattering, ARPES and tunnelling data it is concluded that the second scenario is not at all supported. Neither can one distinguish a small and a large pseudogap as is often done. T* is an energy scale which falls abruptly to zero at p=0.19.Comment: 13 pages, 11 figures, a response to confusion at M^2S Conference, Houston, regarding the phase behaviour of the HTS cuprates. Submitted to Physica C, 2 May 2000. More references added as well as section on c-axis resistivit

The semiology of changing brand image

This article considers the attempted change to the image of an established brand by studying the semiotics within the brand’s historical advertising campaigns. The use of semiotics to study the interpretation of messages is discussed, and the link between interpretation of messages and advertising effectiveness in changing brand image is explored. The authors deconstruct advertisements of a brand to provide a model containing opposing dialectics that may aid managers by highlighting alternative symbolic messages contained in advertisements. Oncwe identified, these alternative symbolic messages may be used to help change brand image and influence advertising effectiveness. Although the study focuses upon a major brand of beer, this is an industry in which there are numerous small firms, and many of those have constrained marketing budgets, and thus need to make sure that their advertising is effective. Equally, entrepreneurial marketing is not to found only in the small firm, and the case study discusses a radical and imaginative brand repositioning of a well established product

The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice

Immune checkpoint inhibitor therapies targeting PD-1/PD-L1 are now the standard of care in oncology across several hematologic and solid tumor types, including triple negative breast cancer (TNBC). Patients with metastatic or locally advanced TNBC with PD-L1 expression on immune cells occupying 651% of tumor area demonstrated survival benefit with the addition of atezolizumab to nab-paclitaxel. However, concerns regarding variability between immunohistochemical PD-L1 assay performance and inter-reader reproducibility have been raised. High tumor-infiltrating lymphocytes (TILs) have also been associated with response to PD-1/PD-L1 inhibitors in patients with breast cancer (BC). TILs can be easily assessed on hematoxylin and eosin\u2013stained slides and have shown reliable inter-reader reproducibility. As an established prognostic factor in early stage TNBC, TILs are soon anticipated to be reported in daily practice in many pathology laboratories worldwide. Because TILs and PD-L1 are parts of an immunological spectrum in BC, we propose the systematic implementation of combined PD-L1 and TIL analyses as a more comprehensive immuno-oncological biomarker for patient selection for PD-1/PD-L1 inhibition-based therapy in patients with BC. Although practical and regulatory considerations differ by jurisdiction, the pathology community has the responsibility to patients to implement assays that lead to optimal patient selection. We propose herewith a risk-management framework that may help mitigate the risks of suboptimal patient selection for immuno-therapeutic approaches in clinical trials and daily practice based on combined TILs/PD-L1 assessment in BC. \ua9 2020 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd